562P Acquired genomic alterations on first-line chemotherapy (CT) + cetuximab in advanced colorectal cancer (mCRC): Circulating tumor (ct)DNA analysis of the randomized phase II trial TIME-PRODIGE-28
Boige, V., Bouche, O., Mulot, C., Evesque, L., Ben Abdelghani, M., Phelip, J.M., Mineur, L., Galais, M.P., Villing, A-L., Hautefeuille, V., Fouchardiere, C. de la, Genet, D., Lassoued, S., Carnot, A., Mitry, E., Jacquot, S., Serazin, D., Brument, E., Winter, A., Blons, H.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article